Related references
Note: Only part of the references are listed.Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
Serena Lucotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
Christopher D. Cluxton et al.
PLOS ONE (2019)
Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis
Yohei Hisada et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents
Xiaohong Ruby Xu et al.
BLOOD (2018)
Distant Relations: Macrophage Functions in the Metastatic Niche
Geneva R. Doak et al.
TRENDS IN CANCER (2018)
Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer
Heidi Griesmann et al.
GUT (2017)
The regulation of pre-metastatic niche formation by neutrophils
Jadwiga Jablonska et al.
ONCOTARGET (2017)
Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1
Sara P. Y. Che et al.
FRONTIERS IN ONCOLOGY (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Christopher Coyle et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis
Sun-Wei Guo et al.
HUMAN REPRODUCTION (2016)
Platelet-Derived Ectosomes Reduce NK Cell Function
Salima Sadallah et al.
JOURNAL OF IMMUNOLOGY (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Juwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Asaf Spiegel et al.
CANCER DISCOVERY (2016)
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma
Dusten Unruh et al.
ONCOTARGET (2016)
Platelets at the interface of thrombosis, inflammation, and cancer
Aime T. Franco et al.
BLOOD (2015)
Protease-activated receptors (PARs)-biology and role in cancer invasion and metastasis
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2015)
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Stefanie K. Wculek et al.
NATURE (2015)
Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
Ling Ding et al.
ONCOTARGET (2015)
Platelets guide the formation of early metastatic niches
Myriam Labelle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Adaptations of natural killer cells to self-MHC class I
Stephanie Bessoles et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor and its microenvironment: A synergistic interplay
Veronica Catalano et al.
SEMINARS IN CANCER BIOLOGY (2013)
The relationship between tissue factor and cancer progression: insights from bench and bedside
Yascha W. van den Berg et al.
BLOOD (2012)
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
Theresa Placke et al.
CANCER RESEARCH (2012)
Prevalence of malignancies among U.S. male patients with haemophilia: a review of the Haemophilia Surveillance System
A. L. Dunn et al.
HAEMOPHILIA (2012)
Platelet-leukocyte interactions in thrombosis
Chiara Cerletti et al.
THROMBOSIS RESEARCH (2012)
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study
Vittorio Pengo et al.
BLOOD (2011)
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
Myriam Labelle et al.
CANCER CELL (2011)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
Hans-Georg Kopp et al.
CANCER RESEARCH (2009)
Role of Tissue Factor in Cancer
Raj S. Kasthuri et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Alternatively spliced tissue factor induces angiogenesis through integrin ligation
Y. W. van den Berg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and -independent mechanisms
Joseph S. Palumbo et al.
BLOOD (2007)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
S Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
